What is AdhereTech?
AdhereTech operates as a specialized digital health entity focused on the intersection of behavioral science and medication management. Its flagship offering, the Aidia System, functions as an integrated, technology-driven platform designed to facilitate real-time communication between patients and their care teams. By providing actionable insights, the company enables pharmaceutical manufacturers and specialty pharmacies to improve medication adherence rates significantly. The firm's market position is defined by its ability to integrate seamlessly into existing healthcare workflows, thereby transforming passive medication regimens into active, data-informed health journeys. Through its focus on human-centric design, AdhereTech addresses the critical challenge of non-adherence, which remains a primary driver of suboptimal health outcomes and increased systemic costs.
How much funding has AdhereTech raised?
AdhereTech has raised a total of $1.8M across 2 funding rounds:
Other Financing Round
$20K
Series A
$1.8M
Other Financing Round (2011): $20K with participation from Blueprint Health
Series A (2014): $1.8M, investors not publicly disclosed
Key Investors in AdhereTech
Blueprint Health
Blueprint Health is a prominent healthcare accelerator focused on nurturing entrepreneurs to develop innovative healthcare IT companies through intensive mentorship and strategic network access.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for AdhereTech?
With the recent influx of capital, AdhereTech is positioned to accelerate its enterprise-level expansion and deepen its integration with major pharmaceutical partners. The strategic roadmap likely involves scaling the Aidia System to accommodate larger patient populations and enhancing the platform's predictive analytics capabilities. As the healthcare industry increasingly prioritizes patient-centric digital tools, AdhereTech is well-positioned to capitalize on the growing demand for remote monitoring and behavioral intervention technologies. Future growth will likely focus on expanding its footprint within the specialty pharmacy sector, where the need for high-touch, technology-enabled adherence support is most acute. By maintaining its focus on measurable health outcomes, the company is poised to solidify its role as an essential infrastructure provider in the modern digital health ecosystem.
See full AdhereTech company page
